Cardiology
RSSArticles
-
Pharmacology Watch: Statins and Cognition — More to the Story?
Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions. -
Stroke Risk with Warfarin Interruption
The risk of interrupting prophylactic warfarin for stroke prevention in atrial fibrillation (AF) patients is unclear. Thus, these investigators from Denmark evaluated their national health registry and found 102,591 patients > age 30 with a first-time hospitalization for AF between 1997 and 2008. -
FFR-Guided PCI vs Medical Therapy in Stable Coronary Artery Disease
In patients with stable coronary artery disease (CAD), medical therapy is the mainstay of treatment. Percutaneous coronary intervention (PCI) guided by angiographic stenosis is more effective than medical therapy at reducing angina, but does not change the rate of death or myocardial infarction (MI). -
Management of Atrial Fibrillation in Chronic Kidney Disease Patients
Patients with chronic kidney disease or who have had renal replacement therapy have often been excluded from trials of anticoagulation in atrial fibrillation (AF). In this study, the authors analyzed data from hospitalized patients with nonvalvular AF in Denmark from 1997 through 2008. Patients with chronic kidney disease with and without renal replacement therapy were identified from a national registry. -
Clinical Cardiology Alert - Full October 2012 Issue in PDF
-
Emergency Medicine Reports August 27, 2012 Issue in PDF
-
Overdose of Oral Antidiabetic Medications and Insulin
Treating the hypoglycemia and metabolic derangements caused by antidiabetic medications, especially in massive overdose, are dynamic as new agents are introduced. -
FDA actions
-
Pharmacology Watch - Full December 2012 Issue in PDF
-
Chemotherapy often misunderstood